|Day Low/High||0.67 / 0.72|
|52 Wk Low/High||0.49 / 1.40|
A key European cancer research meeting this week will include drug presentations from Dendreon, Amgen, ImmunoGen and others.
Several stocks trading below $10, including SinoCoking Coal, were moving on above-average volume Monday.
Oxigene's thyroid cancer drug boost survival but study results marred by too few patients and lack of statistical significance.
Several stocks trading below $5, including Trubion Pharmaceuticals, were poised to move on above-average volume Friday.
Another eight small-cap companies are on watch by the Nasdaq to be delisted in six months.
Encouraging Safety and Outcome Data Recently Reported at the 2010 ASCO Annual Meeting
Adam Feuerstein answers readers' questions about health care- and drug-related companies.
Highlights from Adam Feuerstein's live coverage of the ASCO annual meeting Saturday and Sunday.
Here are the highlights from the second full day of clinical data presentations at ASCO 2010.
Oxigene says Arthur Laffer resigned from the board of directors to pursue other interests
Small-cap cancer drugs get a lift before the American Society of Clinical Oncology's annual meeting.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.